glp-1 health risks Overdoses Are Rising as Telehealth Weight-Loss Prescriptions Boom The GLP-1 Agonists and Obesity:

- not on medical treatment for prostate cancer

At a glance: RDA: Men: 1.3 mg/day | Women: 1.1 mg/day UL: Not established (insufficient evidence to set a tolerable upper limit) [ref] Forms of riboflavin found in supplements: Riboflavin is available in two forms: riboflavin 5-phosphatase (R5P), the active form that doesnt need to be converted

This is one more reason these decisions belong with a healthcare professional and outside the scope of DIY use

A 2025 database study published in the International Journal of Impotence Research found that non-diabetic obese men prescribed semaglutide for weight loss had a 4.5-fold higher risk of erectile dysfunction and nearly double the risk of testosterone deficiency compared to matched controls not taking the drug

Certified Gluten Free (GFCO) Halal Certified Kosher (U)